Mattias Bergqvist has joined the Board of Directors to support Scandinavian CRO (SCRO).
Bergqvist has almost 25 years of experience in the pharma and biotech industry, and his experience in clinical research and development has included varying roles as sponsor, investigator, and strategic consultant. As a consultant, he had the opportunity of working with several small- to medium- enterprises (SME) within pharma and biotech. In addition, his previous roles as Marketing and Brand Director at AstraZeneca helped him build a niche in the therapeutic area of oncology. He is currently Clinical Development Director at Biovica.
”Mattias’ proven expertise in oncology will give us valuable insights into this important area and his extensive experience working with SMEs will add value to SCRO, and to our customers, as we continually improve to meet their evolving needs,” says Ulrika Hammarström Lüllmaa, CEO.
Bergqvist is looking forward to delivering value to SCRO’s partners and helping the business grow during this critical expansion phase.